Goldberg Andrew D. 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Jun 26, 2023
Insider Transaction Report
Form 4
Goldberg Andrew D.
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-22+5,000→ 5,000 totalExercise: $17.99Exp: 2033-06-21→ Common Stock (5,000 underlying) - Award
Restricted Stock Units
2023-06-22+3,350→ 3,350 total→ Common Stock (3,350 underlying)
Footnotes (3)
- [F1]Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.